Utilizzo della scintigrafia con octreotide marcato nella diagnosi delle recidive di tumori neuroendocrini del polmone. Risultati preliminari

A. Oliaro; P. Filosso; M. Bello; G. Bisi; A. Muni; C. Casadio; B. Greco; E. Ruffini; G. Maggi

Utilizzo della scintigrafia con octreotide marcato nella diagnosi delle recidive di tumori neuroendocrini del polmone. Risultati preliminari

A. Oliaro, P. Filosso, M. Bello, G. Bisi, A. Muni, C. Casadio, B. Greco, E. Ruffini, G. Maggi

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Background. The authors report their experience in the use of ¹¹¹In-DTPA-octreotide scintigraphy (Octreoscan) in detecting the recurrences of neuroendocrine carcinomas of the lung, already resected. Methods. From july 1995 to february 1996, at the Department of Thoracic Surgery of the University of Torino four cases of carcinoid syndrome were observed in four patients who underwent lobectomy for bronchopulmonary carcinoid. Results. The scintigraphy allowed to demonstrate the presence of liver metastases in one case, and mediastinal recurrences in the other, confirmed by traditional radiological examinations and by histology. All the patients started a medical therapy with octreotide at the dose of 1500 μg/die followed by a good control of the symptoms.

Titolo tradotto del contributo	Octreotide scintigraphy in the diagnosis of recurrences of lung neuroendocrine carcinomas. Preliminary results
Lingua originale	Italian
pagine (da-a)	177-179
Numero di pagine	3
Rivista	Chirurgia (Turin)
Volume	10
Numero di pubblicazione	2
Stato di pubblicazione	Pubblicato - 1997
Pubblicato esternamente	Sì

Keywords

Carcinoma
Lung neoplasms
Malignant carcinoid syndrome
Neuroendocrine
Neuroendocrine tumors
Octreotide diagnostic use
Radio nuclide imaging

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{a577c7f869444cf0b6975943dae09990,

title = "Utilizzo della scintigrafia con octreotide marcato nella diagnosi delle recidive di tumori neuroendocrini del polmone. Risultati preliminari",

abstract = "Background. The authors report their experience in the use of 111In-DTPA-octreotide scintigraphy (Octreoscan) in detecting the recurrences of neuroendocrine carcinomas of the lung, already resected. Methods. From july 1995 to february 1996, at the Department of Thoracic Surgery of the University of Torino four cases of carcinoid syndrome were observed in four patients who underwent lobectomy for bronchopulmonary carcinoid. Results. The scintigraphy allowed to demonstrate the presence of liver metastases in one case, and mediastinal recurrences in the other, confirmed by traditional radiological examinations and by histology. All the patients started a medical therapy with octreotide at the dose of 1500 μg/die followed by a good control of the symptoms.",

keywords = "Carcinoma, Lung neoplasms, Malignant carcinoid syndrome, Neuroendocrine, Neuroendocrine tumors, Octreotide diagnostic use, Radio nuclide imaging",

author = "A. Oliaro and P. Filosso and M. Bello and G. Bisi and A. Muni and C. Casadio and B. Greco and E. Ruffini and G. Maggi",

year = "1997",

language = "Italian",

volume = "10",

pages = "177--179",

journal = "Chirurgia (Turin)",

issn = "0394-9508",

publisher = "Minerva Medica",

number = "2",

}

TY - JOUR

T1 - Utilizzo della scintigrafia con octreotide marcato nella diagnosi delle recidive di tumori neuroendocrini del polmone. Risultati preliminari

AU - Oliaro, A.

AU - Filosso, P.

AU - Bello, M.

AU - Bisi, G.

AU - Muni, A.

AU - Casadio, C.

AU - Greco, B.

AU - Ruffini, E.

AU - Maggi, G.

PY - 1997

Y1 - 1997

N2 - Background. The authors report their experience in the use of 111In-DTPA-octreotide scintigraphy (Octreoscan) in detecting the recurrences of neuroendocrine carcinomas of the lung, already resected. Methods. From july 1995 to february 1996, at the Department of Thoracic Surgery of the University of Torino four cases of carcinoid syndrome were observed in four patients who underwent lobectomy for bronchopulmonary carcinoid. Results. The scintigraphy allowed to demonstrate the presence of liver metastases in one case, and mediastinal recurrences in the other, confirmed by traditional radiological examinations and by histology. All the patients started a medical therapy with octreotide at the dose of 1500 μg/die followed by a good control of the symptoms.

AB - Background. The authors report their experience in the use of 111In-DTPA-octreotide scintigraphy (Octreoscan) in detecting the recurrences of neuroendocrine carcinomas of the lung, already resected. Methods. From july 1995 to february 1996, at the Department of Thoracic Surgery of the University of Torino four cases of carcinoid syndrome were observed in four patients who underwent lobectomy for bronchopulmonary carcinoid. Results. The scintigraphy allowed to demonstrate the presence of liver metastases in one case, and mediastinal recurrences in the other, confirmed by traditional radiological examinations and by histology. All the patients started a medical therapy with octreotide at the dose of 1500 μg/die followed by a good control of the symptoms.

KW - Carcinoma

KW - Lung neoplasms

KW - Malignant carcinoid syndrome

KW - Neuroendocrine

KW - Neuroendocrine tumors

KW - Octreotide diagnostic use

KW - Radio nuclide imaging

UR - https://www.scopus.com/pages/publications/0030808347

M3 - Articolo in rivista

SN - 0394-9508

VL - 10

SP - 177

EP - 179

JO - Chirurgia (Turin)

JF - Chirurgia (Turin)

IS - 2

ER -

Utilizzo della scintigrafia con octreotide marcato nella diagnosi delle recidive di tumori neuroendocrini del polmone. Risultati preliminari

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo